Global Human Milk Oligosaccharides Market Growth 2025-2031

Publication ID:

LPI03256836

Publication Date:

March 27, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Food Processing [2]

Food [3]

Food & Beverages [4]

Description:

The global Human Milk Oligosaccharides market size is predicted to grow from US$ 416 million in 2025 to US$ 513 million in 2031; it is expected to grow at a CAGR of 3.6% from 2025 to 2031.
Human Milk Oligosaccharides (HMO) are a class of complex carbohydrates naturally found in human breast milk. They are composed of multiple sugar units linked by glycosidic bonds. HMOs are one of the most abundant components in human milk after fat, protein, and lactose, and their concentration is significantly higher in human milk compared to other mammals. HMOs play a crucial role in infant health, serving as prebiotics that promote the growth of beneficial bacteria, such as bifidobacteria, helping to establish a healthy gut microbiome and enhance immune system function.
HMOs vary in structure, including monosaccharides, disaccharides, trisaccharides, and longer polysaccharide chains. Different types of HMOs have distinct biological functions, helping to combat pathogen invasion, reduce inflammation, and support brain development. While HMOs are primarily found in human milk, advances in technology have made it possible to extract and synthesize these oligosaccharides through fermentation and chemical processes for use in commercial products like infant formula, functional foods, and health supplements.
With ongoing research into the benefits of HMOs in infant health and other wellness applications, the demand for human milk oligosaccharides has been steadily increasing, particularly in infant formula and adult prebiotic foods.
Market Development Opportunities and Key Drivers:
As consumer awareness of health increases, especially in regard to infant health, the market for human milk oligosaccharides (HMOs) is experiencing significant growth opportunities. In recent years, extensive research on the role of HMOs in infant health has led more infant formula manufacturers to incorporate HMOs into their products to support immune function and gut health. Additionally, HMOs have shown potential in adult health applications, particularly in maintaining gut microbiome balance and enhancing immune function, opening new growth avenues for the market. As the global population ages and the demand for functional foods rises, there is also growing demand for prebiotic products targeting adults.
Market Risks:
Despite the promising outlook for the HMO market, there are several risks. First, the production of HMOs is complex and costly, which may hinder product accessibility and price competitiveness. Second, the HMO supply chain is intricate, involving multiple stages such as raw material extraction and fermentation. Any technological challenges or disruptions in production could affect the stability of the entire supply chain. Moreover, global regulatory and standard differences may pose challenges to market expansion, particularly in terms of varying regulatory policies and certification requirements in different countries.
Market Concentration:
Currently, the HMO production market is relatively concentrated, with several leading biotech and pharmaceutical companies dominating the industry. These companies have advanced fermentation and biosynthesis technologies that enable large-scale production while maintaining high quality. However, as technology advances and the market expands, more small and medium-sized enterprises are expected to enter the market, fostering competition and innovation.
Downstream Demand Trends:
The downstream demand for HMOs is mainly concentrated in infant formula, prebiotic foods and supplements, and personalized nutrition products. As consumers increasingly demand personalized and functional nutrition products, the market for HMOs as a functional ingredient will continue to grow. Additionally, the potential for HMOs in aging populations is being recognized, particularly for supporting gut health and immune systems in elderly individuals.
Latest Technologies:
The production technology for HMOs is continually evolving, with innovations in fermentation and biosynthesis reducing production costs. Furthermore, the application of genetic engineering and synthetic biology has opened up possibilities for customized HMO production, allowing for optimized efficiency and yields through genetically modified microorganisms.
The 鈥淗uman Milk Oligosaccharides Industry Forecast鈥� looks at past sales and reviews total world Human Milk Oligosaccharides sales in 2024, providing a comprehensive analysis by region and market sector of projected Human Milk Oligosaccharides sales for 2025 through 2031. With Human Milk Oligosaccharides sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Milk Oligosaccharides industry.
This Insight Report provides a comprehensive analysis of the global Human Milk Oligosaccharides landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Human Milk Oligosaccharides portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Human Milk Oligosaccharides market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Milk Oligosaccharides and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Milk Oligosaccharides.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Milk Oligosaccharides market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Fucosyllactose
LNT & LNNT
Sialyllactose
Segmentation by Application:
Infant Formula
Other Applications
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Abbott
Dupont (Inbiose)
DSM (Glycom)
Chr. Hansen (Jennewein)
BASF
FrieslandCampina
Key Questions Addressed in this Report
What is the 10-year outlook for the global Human Milk Oligosaccharides market?
What factors are driving Human Milk Oligosaccharides market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Human Milk Oligosaccharides market opportunities vary by end market size?
How does Human Milk Oligosaccharides break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Human Milk Oligosaccharides Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Human Milk Oligosaccharides by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Human Milk Oligosaccharides by Country/Region, 2020, 2024 & 2031
2.2 Human Milk Oligosaccharides Segment by Type
2.2.1 Fucosyllactose
2.2.2 LNT & LNNT
2.2.3 Sialyllactose
2.3 Human Milk Oligosaccharides Sales by Type
2.3.1 Global Human Milk Oligosaccharides Sales Market Share by Type (2020-2025)
2.3.2 Global Human Milk Oligosaccharides Revenue and Market Share by Type (2020-2025)
2.3.3 Global Human Milk Oligosaccharides Sale Price by Type (2020-2025)
2.4 Human Milk Oligosaccharides Segment by Application
2.4.1 Infant Formula
2.4.2 Other Applications
2.5 Human Milk Oligosaccharides Sales by Application
2.5.1 Global Human Milk Oligosaccharides Sale Market Share by Application (2020-2025)
2.5.2 Global Human Milk Oligosaccharides Revenue and Market Share by Application (2020-2025)
2.5.3 Global Human Milk Oligosaccharides Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Human Milk Oligosaccharides Breakdown Data by Company
3.1.1 Global Human Milk Oligosaccharides Annual Sales by Company (2020-2025)
3.1.2 Global Human Milk Oligosaccharides Sales Market Share by Company (2020-2025)
3.2 Global Human Milk Oligosaccharides Annual Revenue by Company (2020-2025)
3.2.1 Global Human Milk Oligosaccharides Revenue by Company (2020-2025)
3.2.2 Global Human Milk Oligosaccharides Revenue Market Share by Company (2020-2025)
3.3 Global Human Milk Oligosaccharides Sale Price by Company
3.4 Key Manufacturers Human Milk Oligosaccharides Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Human Milk Oligosaccharides Product Location Distribution
3.4.2 Players Human Milk Oligosaccharides Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Human Milk Oligosaccharides by Geographic Region
4.1 World Historic Human Milk Oligosaccharides Market Size by Geographic Region (2020-2025)
4.1.1 Global Human Milk Oligosaccharides Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Human Milk Oligosaccharides Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Human Milk Oligosaccharides Market Size by Country/Region (2020-2025)
4.2.1 Global Human Milk Oligosaccharides Annual Sales by Country/Region (2020-2025)
4.2.2 Global Human Milk Oligosaccharides Annual Revenue by Country/Region (2020-2025)
4.3 Americas Human Milk Oligosaccharides Sales Growth
4.4 APAC Human Milk Oligosaccharides Sales Growth
4.5 Europe Human Milk Oligosaccharides Sales Growth
4.6 Middle East & Africa Human Milk Oligosaccharides Sales Growth
5 Americas
5.1 Americas Human Milk Oligosaccharides Sales by Country
5.1.1 Americas Human Milk Oligosaccharides Sales by Country (2020-2025)
5.1.2 Americas Human Milk Oligosaccharides Revenue by Country (2020-2025)
5.2 Americas Human Milk Oligosaccharides Sales by Type (2020-2025)
5.3 Americas Human Milk Oligosaccharides Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Milk Oligosaccharides Sales by Region
6.1.1 APAC Human Milk Oligosaccharides Sales by Region (2020-2025)
6.1.2 APAC Human Milk Oligosaccharides Revenue by Region (2020-2025)
6.2 APAC Human Milk Oligosaccharides Sales by Type (2020-2025)
6.3 APAC Human Milk Oligosaccharides Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Human Milk Oligosaccharides by Country
7.1.1 Europe Human Milk Oligosaccharides Sales by Country (2020-2025)
7.1.2 Europe Human Milk Oligosaccharides Revenue by Country (2020-2025)
7.2 Europe Human Milk Oligosaccharides Sales by Type (2020-2025)
7.3 Europe Human Milk Oligosaccharides Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Human Milk Oligosaccharides by Country
8.1.1 Middle East & Africa Human Milk Oligosaccharides Sales by Country (2020-2025)
8.1.2 Middle East & Africa Human Milk Oligosaccharides Revenue by Country (2020-2025)
8.2 Middle East & Africa Human Milk Oligosaccharides Sales by Type (2020-2025)
8.3 Middle East & Africa Human Milk Oligosaccharides Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Human Milk Oligosaccharides
10.3 Manufacturing Process Analysis of Human Milk Oligosaccharides
10.4 Industry Chain Structure of Human Milk Oligosaccharides
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Human Milk Oligosaccharides Distributors
11.3 Human Milk Oligosaccharides Customer
12 World Forecast Review for Human Milk Oligosaccharides by Geographic Region
12.1 Global Human Milk Oligosaccharides Market Size Forecast by Region
12.1.1 Global Human Milk Oligosaccharides Forecast by Region (2026-2031)
12.1.2 Global Human Milk Oligosaccharides Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Human Milk Oligosaccharides Forecast by Type (2026-2031)
12.7 Global Human Milk Oligosaccharides Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Abbott
13.1.1 Abbott Company Information
13.1.2 Abbott Human Milk Oligosaccharides Product Portfolios and Specifications
13.1.3 Abbott Human Milk Oligosaccharides Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Abbott Main Business Overview
13.1.5 Abbott Latest Developments
13.2 Dupont (Inbiose)
13.2.1 Dupont (Inbiose) Company Information
13.2.2 Dupont (Inbiose) Human Milk Oligosaccharides Product Portfolios and Specifications
13.2.3 Dupont (Inbiose) Human Milk Oligosaccharides Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Dupont (Inbiose) Main Business Overview
13.2.5 Dupont (Inbiose) Latest Developments
13.3 DSM (Glycom)
13.3.1 DSM (Glycom) Company Information
13.3.2 DSM (Glycom) Human Milk Oligosaccharides Product Portfolios and Specifications
13.3.3 DSM (Glycom) Human Milk Oligosaccharides Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 DSM (Glycom) Main Business Overview
13.3.5 DSM (Glycom) Latest Developments
13.4 Chr. Hansen (Jennewein)
13.4.1 Chr. Hansen (Jennewein) Company Information
13.4.2 Chr. Hansen (Jennewein) Human Milk Oligosaccharides Product Portfolios and Specifications
13.4.3 Chr. Hansen (Jennewein) Human Milk Oligosaccharides Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Chr. Hansen (Jennewein) Main Business Overview
13.4.5 Chr. Hansen (Jennewein) Latest Developments
13.5 BASF
13.5.1 BASF Company Information
13.5.2 BASF Human Milk Oligosaccharides Product Portfolios and Specifications
13.5.3 BASF Human Milk Oligosaccharides Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 BASF Main Business Overview
13.5.5 BASF Latest Developments
13.6 FrieslandCampina
13.6.1 FrieslandCampina Company Information
13.6.2 FrieslandCampina Human Milk Oligosaccharides Product Portfolios and Specifications
13.6.3 FrieslandCampina Human Milk Oligosaccharides Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 FrieslandCampina Main Business Overview
13.6.5 FrieslandCampina Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂